UVC radiation induces downregulation of EGF Receptor via phosphorylation at serine 1046/1047 in human pancreatic cancer cells

Radiation Research

Volumn 176, Issue 5, 2011, Pages 565-574

  Yamauchi, Takahiro ^a   Adachi, Seiji ^a   Yasuda, Ichiro ^a   Nakashima, Masanori ^a   Kawaguchi, Junji ^a   Nishii, Yumi ^a   Yoshioka, Takashi ^a   Okano, Yukio ^a   Hirose, Yoshinobu ^a   Kozawab, Osamu ^a   Moriwakia, Hisataka ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SERINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIVITY; ULTRAVIOLET C RADIATION;

CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SERINE; ULTRAVIOLET RAYS;

EID: 80155175721     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2445.1     Document Type: Article

References (39)

1. Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004; 102:37-46. (Pubitemid 38429984)
2. Tobita K, Kijima H, Dowaki S, Kashiwagi H, Ohtani Y, Oida Y, et al. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis. Int J Mol Med 2003; 11:305-9.
3. Marshall J. Clinical implications of the mechanism of epidermal growth factor receptor inhibitors. Cancer 2006; 107:1207-18. (Pubitemid 44452768)
4. Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal 2007; 19:2013-23. (Pubitemid 47353811)
5. Faller BA, Burtness B. Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy. Biologics 2009; 3:419-28.
6. Massie C, Mills IG. The developing role of receptors and adaptors. Nat Rev Cancer 2006; 6:403-9.
7. Levkowitz G, Waterman H, Ettenberg SA, Katz M, Tsygankov AY, Alroy I, et al. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol Cell 1999; 4:1029-40. (Pubitemid 30054908)
8. Countaway JL, McQuilkin P, Girones N, Davis RJ. Multisite phosphorylation of the epidermal growth factor receptor. Use of site-directed mutagenesis to examine the role of serine/threonine phosphorylation. J Biol Chem 1990; 265:3407-16.
9. Countaway JL, Nairn AC, Davis RJ. Mechanism of desensitization of the epidermal growth factor receptor protein-tyrosine kinase. J Biol Chem 1992; 267:1129-40.
10. Theroux SJ, Latour DA, Stanley K, Raden DL, Davis RJ. Signal transduction by the epidermal growth factor receptor is attenuated by a COOH-terminal domain serine phosphorylation site. J Biol Chem 1992; 267:16620-6.
11. Adachi S, Natsume H, Yamauchi J, Matsushima-Nishiwaki R, Joe AK, Moriwaki H, et al. p38 MAP kinase controls EGF receptor downregulation via phosphorylation at Ser1046/1047. Cancer Lett 2009; 277:108-13.
12. Yoon JH, Prakash L, Prakash S. Highly error-free role of DNA polymerase eta in the replicative bypass of UV-induced pyrimidine dimers in mouse and human cells. Proc Natl Acad Sci U S A 2009; 106:18219-24.
13. Latonen L, Laiho M. Cellular UV damage responses - functions of tumor suppressor p53. Biochim Biophys Acta 2005; 1755:71-89. (Pubitemid 40982559)
14. Olsen BB, Neves-Petersen MT, Klitgaard S, Issinger OG, Petersen SB. UV light blocks EGFR signalling in human cancer cell lines. Int J Oncol 2007; 30:181-5.
15. Kim SC, Park SS, Lee YJ. Effect of UV irradiation on colorectal cancer cells with acquired TRAIL resistance. J Cell Biochem 2008; 104:1172-80. (Pubitemid 351961692)
16. Zwang Y, Yarden Y. p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J 2006; 25:4195-206. (Pubitemid 44435217)
17. Adachi S, Nagao T, Ingolfsson HI, Maxfield FR, Andersen OS, Kopelovich L, et al. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 2007; 67:6493-501. (Pubitemid 47037535)
18. Adachi S, Nagao T, To S, Joe AK, Shimizu M, Matsushima- Nishiwaki R, et al. (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis 2008; 29:1986-93.
19. Papageorgio C, Perry MC. Epidermal growth factor receptor-targeted therapy for pancreatic cancer. Cancer Invest 2007; 25:647-57. (Pubitemid 350135745)
20. Oksvold MP, Huitfeldt HS, Ostvold AC, Skarpen E. UV induces tyrosine kinase-independent internalisation and endosome arrest of the EGF receptor. J Cell Sci 2002; 115:793-803. (Pubitemid 34196339)
21. Meisenhelder J, Suh PG, Rhee SG, Hunter T. Phospholipase Cgamma is a substrate for the PDGF and EGF receptor proteintyrosine kinases in vivo and in vitro. Cell 1989; 7:1109-22. (Pubitemid 19169807)
22. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992; 70:431-42.
23. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, et al. Association of the Shc and Grb2/Sem5 SH2- containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360:689-92. (Pubitemid 23007687)
24. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364:229-33.
25. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J 2007; 408:297-315.
26. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogenactivated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270:27489-94.
27. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun Nterminal kinase. Proc Natl Acad Sci U S A 2001; 98:13681-6. (Pubitemid 33115958)
28. Hu Y, Qiao L, Wang S, Rong SB, Meuillet EJ, Berggren M, et al. 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J Med Chem 2000; 43:3045-51. (Pubitemid 30626762)
29. Waterman H, Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett 2001; 490:142-52. (Pubitemid 32171933)
30. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000; 103:211-25.
31. Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T, Liu YC. The tyrosine kinase negative regulator c-Cbl as a RINGtype, E2-dependent ubiquitin-protein ligase. Science 1999; 286: 309-12.
32. Waterman H, Levkowitz G, Alroy I, Yarden Y. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. J Biol Chem 1999; 274:22151-4.
33. Adachi S, Shimizu M, Shirakami Y, Yamauchi J, Natsume H, Matsushima-Nishiwaki R, et al. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/ 1047 by p38 MAPK in colon cancer cells. Carcinogenesis 2009; 30:1544-52.
34. Oksvold MP, Thien CB, Widerberg J, Chantry A, Huitfeldt HS, Langdon WY. UV-radiation-induced internalization of the epidermal growth factor receptor requires distinct serine and tyrosine residues in the cytoplasmic carboxy-terminal domain. Radiat Res 2004; 161:685-91. (Pubitemid 39149577)
35. Adachi S, Yasuda I, Nakashima M, Yamauchi T, Yamauchi J, Natsume H, et al. HSP90 inhibitors induce desensitization of EGF receptor via p38 MAPK-mediated phosphorylation at Ser1046/1047 in human pancreatic cancer cells. Oncol Rep 2010; 23:1709-14.
36. Kennedy NJ, Cellurale C, Davis RJ. A radical role for p38 MAPK in tumor initiation. Cancer Cell 2007; 11:101-3. (Pubitemid 46209855)
37. Feng FY, Varambally S, Tomlins SA, Chun PY, Lopez CA, Li X, et al. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Oncogene 2007; 26:3431-9. (Pubitemid 46788888)
38. Winograd-Katz SE, Levitzki A. Cisplatin induces PKB/Akt activation and p38 (MAPK) phosphorylation of the EGF receptor. Oncogene 2006; 25:7381-90. (Pubitemid 44853429)
39. Theroux SJ, Stanley K, Campbell DA, Davis RJ. Mutational removal of the major site of serine phosphorylation of the epidermal growth factor receptor causes potentiation of signal transduction: role of receptor down-regulation. Mol Endocrinol 1992; 6:1849-57.